Metformin pills for melasma in Latin American women
Treatments studied
Part of Skin clinical trials.
This study tests if taking metformin pills can help treat melasma (dark patches on the skin) in Latin American women. It may be a new option for those whose melasma hasn't improved with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman of Latin American background
- You are 21 years old or older
- You have been diagnosed with melasma that is on the surface or mixed layers of the skin
- You are not pregnant or breastfeeding
- You have not used hydroquinone or tretinoin creams in the last 2 months
- You have not had laser, peels, microdermabrasion, or microneedling in the last 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
This trial tests whether taking tranexamic acid (a medicine that helps reduce pigmentation) along with a skin treatment called microneedling is more effective for treating melasma than microneedling alone. It aims to help women with facial melasma achieve clearer, more even skin tone.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
This trial tests a new gel applied to the skin that combines three ingredients to treat melasma, a condition causing dark patches on the face. It may help lighten these patches and improve skin appearance.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.